← Back to headlines
Clinuvel Reports Continued Profit Streak Despite 12% Share Decline
Australian biotech firm Clinuvel announced its second-half 2026 earnings, maintaining a profit streak even as its stock price dropped 12% following the release.
27 Aug, 09:28 — 27 Aug, 09:28
Sources
Showing 1 of 1 sources
